Diseases and Conditions Researched
Alcoholism
What is the purpose of this trial?
The proposed study is the first to explore the contribution of brain glutamate systems, a major target of ethanol in the brain, to the vulnerability to develop alcoholism. This study may lead to an enhanced understanding of the underlying neurobiological mechanism in high-risk individuals that may lead to the transition from moderate to excessive use of alcohol.
Participation Guidelines
Age: 21 Years - 30 Years
Gender: Both
This trial accepts healthy volunteers.
Click here for
detailed participation information for this trial.
|
Sponsors:
|
VA Connecticut Healthcare System; Yale University |
| Dates: |
December 27, 2007 |
| Last Updated: |
February 14, 2013 |
| Study HIC#: |
0103012310 |
| Clinicaltrials.gov ID: |
NCT00588952
|
Trial Purpose
The proposed study is the first to explore the contribution of brain glutamate systems, a major target of ethanol in the brain, to the vulnerability to develop alcoholism. This study may lead to an enhanced understanding of the underlying neurobiological mechanism in high-risk individuals that may lead to the transition from moderate to excessive use of alcohol.
Participation Guidelines
Age: 21 Years - 30 Years
Gender: Both
This trial accepts healthy volunteers.
Eligibility Criteria
Inclusion Criteria:
1. Male and female between the ages of 21 and 30 years
2. Medically and neurologically healthy on the basis of history, physical examination,
EKG, screening laboratories, absence of current and/or past substance abuse
3. For Family History Positive (FHP) Subjects: Biological father and another first or
second-degree biological relative with history of alcoholism
Exclusion Criteria:
1. DSM-IV psychiatric and substance abuse diagnosis by history on psychiatric evaluation
that includes a structured diagnostic interview (The Semi-Structured Assessment for
the Genetics of alcoholism: SSAGA) and the Wisconsin Scales of Psychosis Proneness
2. History of counseling or psychotherapy; except family therapy centered around another
family member
3. Extended unwillingness to remain alcohol-free for three days prior to testing and for
the duration of the testing period
4. For women: positive pregnancy test at screening or intention to engage in unprotected
sex during the study
5. Alcohol naïve
6. Previous bad experience with ketamine
7. Adoptee and no contact with family members
8. For Family History Negative (FHN) Subjects: NO family history of alcoholism in any
first or second-degree relatives (subjects must reliably report on three first-degree
relatives)
|
Sponsors:
|
VA Connecticut Healthcare System; Yale University |
| Dates: |
December 27, 2007 |
| Last Updated: |
February 14, 2013 |
| Study HIC#: |
0103012310 |
| Clinicaltrials.gov ID: |
NCT00588952
|